查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1373932

补充标靶治疗市场，按类型、按应用、给药途径、国家和地区 - 2023-2030 年行业分析、市场规模、市场份额和预测

Complement-Targeted Therapeutics Market, By Type, By Application, By Route of Administration, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 300 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年，补体标靶治疗市场规模为 72.008 亿美元，2023 年至 2030 年CAGR为 10.5%。

补充标靶治疗市场-市场动态

对罕见和具有挑战性的疾病的有效治疗的未满足的医疗需求将推动市场需求

过去，对各种与补体系统相关的疾病，如PNH、非典型溶血性尿毒症症候群（aHUS）等，都缺乏了解和缺乏特效治疗方法。依库珠单抗和拉维珠单抗等补体标靶药物的出现极大地改变了那些与这些疾病作斗争的个人的前景，在曾经缺乏可行替代品的情况下提供了挽救生命的治疗方法。这项成就促进了补体标靶药物的研究和投资增加，不仅适用于罕见疾病，也适用于自体免疫和发炎性疾病的更广泛应用。这一发展有望改善患者的治疗效果和提高生活品质。

补充标靶治疗市场 - 关键见解

根据我们的研究分析师提供的分析，在 2023 年至 2030 年的预测期内，全球补体标靶治疗市场的年增长率预计约为 10.5%。

补体标靶治疗领域预计将经历大幅增长，这主要是由于针对罕见和挑战性疾病的有效治疗的医疗需求不断上升而未得到满足。

在考虑按类型细分时，2022 年阵发性睡眠性血红蛋白尿症成为主要类别。

从应用细分来看，医院药局在2022年脱颖而出，成为领先类别。

从地理位置来看，北美将在 2022 年成为主要收入来源。

补充标靶治疗市场細項分析：

全球补体标靶治疗市场围绕着几个关键维度构建，包括类型、应用、给药途径和区域。

在类型类别中，市场分为三个主要部分：阵发性夜间血红蛋白尿症和非典型溶血性尿毒症（AHUS）。值得注意的是，阵发性睡眠性血红素尿症领域在市场上占据主导地位。对有效药物的迫切需求是补体标靶疗法市场的驱动力，特别关註解决阵发性睡眠性血红蛋白尿症 (PNH)。 PNH 是一种罕见且可能危及生命的血液疾病，其特征是溶血。依库丽单抗等药物透过减少溶血和提高患者的生活品质彻底改变了 PNH 治疗，强调了这些药物在控制病情方面的重要性。

补充标靶治疗市场 - 地理洞察

从地理来看，该市场遍及北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。在这些地区，各国在塑造商业动态方面发挥着重要作用。

在多种因素的推动下，北美补体标靶治疗市场呈现持续成长。首先，该地区的人口老化导致年龄相关疾病的发生率更高，包括年龄相关性黄斑部病变（AMD），补体标靶药物对此具有重大前景。其次，人们对发性睡眠性血红素尿症（PNH）和非典型溶血性尿毒症症候群（aHUS）等罕见补体相关疾病的认识不断提高，增加了对专门治疗的需求，进一步促进了市场扩张。

补充标靶治疗市场-竞争格局：

补体标靶治疗领域的竞争格局充满活力与创新。成熟的实体历来都占据重要地位，这主要归功于其旗舰药物依库珠单抗（Eculizumab）。然而，随着包括中小企业在内的各类製药公司透过开发补体标靶药物并扩大产品组合进入这一领域，竞争加剧。这种激烈的竞争促进了新药领域的研究和创新，从而增强了补体相关疾病的治疗选择。

目录

第一章：补体标靶治疗市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场摘录
    • 按类型分類的补充标靶治疗市场摘录
    • 按应用分類的补充标靶治疗市场摘录
    • 按给药途径分類的补充标靶治疗市场摘录
    • 按国家/地区分類的补充标靶治疗市场摘录
    • 按地区分類的补充标靶治疗市场摘录
  • 竞争洞察

第 3 章：补体标靶治疗主要市场趋势

  • 补充标靶治疗市场驱动因素
    • 市场驱动因素的影响分析
  • 补充标靶治疗市场的限制
    • 市场限制影响分析
  • 补充标靶治疗市场机会
  • 补体标靶治疗市场未来趋势

第 4 章：补体标靶治疗产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：补充标靶治疗市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：补体标靶治疗市场格局

  • 2022 年补体标靶治疗市占率分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：补充标靶治疗市场 - 按类型

  • 概述
    • 按类型分類的细分市场占有率分析
    • 阵发性睡眠性血红素尿
    • 非典型溶血性尿毒症候群 (AHUS)

第 8 章：补充标靶治疗市场 -按应用

  • 概述
    • 按应用的细分市场占有率分析
    • 医院药房
    • 零售药局
    • 网路药局

第 9 章：补体标靶治疗市场 - 按给药途径

  • 概述
    • 按给药途径分類的细分市占率分析
    • 静脉注射
    • 口服或皮下形式

第 10 章：补充标靶治疗市场 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美补体标靶疗法主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模与预测（按管理途径）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲补体标靶疗法主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按类型）
    • 欧洲市场规模和预测（按应用）
    • 欧洲市场规模与预测（按管理途径）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区补体标靶疗法主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按类型）
    • 亚太地区市场规模与预测（按应用）
    • 亚太地区市场规模与预测（依管理途径）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲补体标靶疗法主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按类型）
    • 拉丁美洲市场规模与预测（按应用）
    • 拉丁美洲市场规模与预测（按管理途径）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲补充标靶疗法主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按类型）
    • 中东和非洲市场规模及预测（按应用）
    • 中东和非洲市场规模及预测（按管理途径）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 补充标靶治疗产业

  • 竞争仪表板
  • 公司简介
    • Alexion Pharmaceuticals
    • Regeneron Pharmaceuticals
    • Apellis Pharmaceuticals
    • Ra Pharmaceuticals
    • Omeros Corporation
    • Achillion Pharmaceuticals
    • Idera Pharmaceuticals
    • Novartis
    • Janssen Pharmaceuticals
    • Biogen
    • Genentech
    • Amgen
    • CSL Behring
    • Alnylam Pharmaceuticals
    • Argenx

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1809

REPORT HIGHLIGHT

Complement-targeted Therapeutics Market size was valued at USD 7,200.8 Million in 2022, expanding at a CAGR of 10.5% from 2023 to 2030.

Complement-targeted medications represent a category of medical treatments designed to modulate the complement system, a pivotal component of the immune system. This system plays a dual role in safeguarding the body against infections while maintaining tissue equilibrium. However, dysregulation can lead to autoimmune disorders, inflammatory conditions, and tissue damage. Complement-targeted medications aim to restore immunological balance by either inhibiting or enhancing specific complement components. They hold the potential to address a diverse array of conditions, ranging from rare hereditary diseases like paroxysmal nocturnal hemoglobinuria (PNH) to more common issues such as age-related macular degeneration (AMD). These therapies mark a promising frontier in the realm of precision medicine.

Complement-targeted Therapeutics Market- Market Dynamics

Unmet medical need for effective treatments for rare and challenging diseases to propel market demand

In the past, various diseases related to the complement system, such as PNH and atypical hemolytic uremic syndrome (aHUS), were characterized by a lack of understanding and a shortage of specific treatments. The advent of complement-targeted medications like eculizumab and ravulizumab has dramatically transformed the outlook for individuals grappling with these conditions, offering life-saving therapies in situations where viable alternatives were once scarce. This accomplishment has catalyzed increased research and investment in complement-targeted drugs, not only for rare diseases but also for broader applications in autoimmune and inflammatory disorders. This development holds the promise of improved patient outcomes and a better quality of life.

Complement-targeted Therapeutics Market- Key Insights

According to the analysis provided by our research analyst, the global market for Complement-targeted Therapeutics is poised to witness an annual growth rate of approximately 10.5% throughout the forecast period spanning from 2023 to 2030.

The Complement-targeted Therapeutics sector is anticipated to experience substantial growth, primarily driven by the escalating unmet medical demands for effective treatments aimed at rare and challenging diseases.

When considering the segmentation by Type, the year 2022 witnessed Paroxysmal Nocturnal Haemoglobinuria as the dominant category.

In terms of Application segmentation, Hospital Pharmacies stood out as the leading category in 2022.

Geographically, North America emerged as the primary revenue generator in the year 2022.

Complement-targeted Therapeutics Market- Segmentation Analysis:

The Global Complement-targeted Therapeutics Market is structured around several key dimensions, including Type, Application, Route of Administration, and Region.

Within the Type category, the market is classified into three primary segments: Paroxysmal Nocturnal Haemoglobinuria and Atypical Haemolytic Uraemic Syndrome (AHUS). Notably, the Paroxysmal Nocturnal Haemoglobinuria sector assumes dominance in the market. The critical demand for effective medications is a driving force in the market for complement-targeted therapeutics, with a specific focus on addressing Paroxysmal Nocturnal Hemoglobinuria (PNH). PNH is a rare and potentially life-threatening blood disorder characterized by hemolysis. Medications like eculizumab have revolutionized PNH treatment by reducing hemolysis and enhancing the quality of life for patients, underscoring the significance of these drugs in managing the condition.

Complement-targeted Therapeutics Market- Geographical Insights

From a geographical standpoint, this market extends across regions including North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. Within these regions, individual countries play a significant role in shaping business dynamics.

The market for complement-targeted therapies in North America has demonstrated continuous growth, driven by a multitude of factors. Firstly, the region's aging population contributes to a higher incidence of age-related conditions, including age-related macular degeneration (AMD), for which complement-targeted medications hold significant promise. Secondly, the increasing awareness of rare complement-related disorders such as paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS) has heightened the demand for specialized treatments, further fostering market expansion.

Complement-targeted Therapeutics Market- Competitive Landscape:

The competitive landscape in the field of complement-targeted therapies is marked by dynamism and innovation. Established entities have historically held prominent positions, primarily due to their flagship drug Soliris (eculizumab). Nevertheless, as a diverse range of pharmaceutical companies, including both small and medium-sized enterprises, enter the arena by developing complement-targeted medications and expanding their portfolios, competition intensifies. This heightened competition fosters research and innovation in the realm of new medications, consequently enhancing treatment options for complement-related disorders.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET KEY PLAYERS

  • Alexion Pharmaceuticals
  • Regeneron Pharmaceuticals
  • Apellis Pharmaceuticals
  • Ra Pharmaceuticals
  • Omeros Corporation
  • Achillion Pharmaceuticals
  • Idera Pharmaceuticals
  • Novartis
  • Janssen Pharmaceuticals
  • Biogen
  • Genentech
  • Amgen
  • CSL Behring
  • Alnylam Pharmaceuticals
  • Argenx

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY TYPE

  • Paroxysmal Nocturnal Haemoglobinuria
  • Atypical Haemolytic Uraemic Syndrome (AHUS)

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY APPLICATION

  • Hospital Pharmacies
  • Retail Pharamacies
  • Online Pharmacies

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY ROUTE OF ADMINISTRATION

  • Intravenously
  • oral or subcutaneous forms

GLOBAL COMPLEMENT-TARGETED THERAPEUTICS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Complement-targeted Therapeutics Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Complement-targeted Therapeutics Market Snippet by Type
    • 2.1.2. Complement-targeted Therapeutics Market Snippet by Application
    • 2.1.3. Complement-targeted Therapeutics Market Snippet by Route of Administration
    • 2.1.4. Complement-targeted Therapeutics Market Snippet by Country
    • 2.1.5. Complement-targeted Therapeutics Market Snippet by Region
  • 2.2. Competitive Insights

3. Complement-targeted Therapeutics Key Market Trends

  • 3.1. Complement-targeted Therapeutics Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Complement-targeted Therapeutics Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Complement-targeted Therapeutics Market Opportunities
  • 3.4. Complement-targeted Therapeutics Market Future Trends

4. Complement-targeted Therapeutics Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Complement-targeted Therapeutics Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Complement-targeted Therapeutics Market Landscape

  • 6.1. Complement-targeted Therapeutics Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Complement-targeted Therapeutics Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Paroxysmal Nocturnal Haemoglobinuria
    • 7.1.3. Atypical Haemolytic Uraemic Syndrome (AHUS)

8. Complement-targeted Therapeutics Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2022 & 2030 (%)
    • 8.1.2. Hospital Pharmacies
    • 8.1.3. Retail Pharamacies
    • 8.1.4. Online Pharmacies

9. Complement-targeted Therapeutics Market - By Route of Administration

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Route of Administration, 2022 & 2030 (%)
    • 9.1.2. Intravenously
    • 9.1.3. oral or subcutaneous forms

10. Complement-targeted Therapeutics Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Complement-targeted Therapeutics Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Complement-targeted Therapeutics Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Complement-targeted Therapeutics Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Complement-targeted Therapeutics Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Complement-targeted Therapeutics Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Route of Administration, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Complement-targeted Therapeutics Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Alexion Pharmaceuticals
    • 11.2.2. Regeneron Pharmaceuticals
    • 11.2.3. Apellis Pharmaceuticals
    • 11.2.4. Ra Pharmaceuticals
    • 11.2.5. Omeros Corporation
    • 11.2.6. Achillion Pharmaceuticals
    • 11.2.7. Idera Pharmaceuticals
    • 11.2.8. Novartis
    • 11.2.9. Janssen Pharmaceuticals
    • 11.2.10. Biogen
    • 11.2.11. Genentech
    • 11.2.12. Amgen
    • 11.2.13. CSL Behring
    • 11.2.14. Alnylam Pharmaceuticals
    • 11.2.15. Argenx

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Complement-targeted Therapeutics Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Complement-targeted Therapeutics Market, by Type 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Complement-targeted Therapeutics Market, by Application 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Route of Administration Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Route of Administration
  • TABLE Global Complement-targeted Therapeutics Market, by Route of Administration 2018-2030 (USD Million)
  • TABLE Complement-targeted Therapeutics Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Complement-targeted Therapeutics Market, by Region 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE North America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Complement-targeted Therapeutics Market, by Route of Administration, 2018-2030 (USD Million)

List of Figures

  • FIGURE Complement-targeted Therapeutics Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Route of Administration segment market share analysis, 2022 & 2030
  • FIGURE Route of Administration segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Europe Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Asia Pacific Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Latin America Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Germany Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE India Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Brazil Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Complement-targeted Therapeutics Market share analysis by country, 2022
  • FIGURE Saudi Arabia Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Complement-targeted Therapeutics Market size, forecast and trend analysis, 2018 to 2030 (USD Million)